Skip to content
Delayed ~15 min

BHVN BIOHAVEN

Health Care · Russell 2000

Next earnings: not announced yet

What 21 analyst firms say about BIOHAVEN: their latest ratings, price targets and how far the stock is from them. How it works

14.48 USD+0.58 (+4.17%) today
Price as of 6 Nov 16:00 ET

Analyst window: Latest analyst report within last 1 year

Analyst view · last 1Y

+47.8%to the avg target 21.40 USD+6.92 USD
Buy 11 · Hold 5 · Sell 1

17 rated views · 21 analyst/firm records · 21 firms

Latest report3 Nov 2026avg report date 20 Jul
Target rangeLowest to highest analyst target, not a forecast

Radar score

  • Russell 2000 · Top Picks · 6MBelow the Radar threshold of 8027
  • Russell 2000 · Safest consensus · 6MBelow the Radar threshold of 8025

Recent analyst activity · last 90 days

Our tracked history has 20 reports on BHVN from 13 analyst firms in the last 90 days (21 firms in the past year).

Comparing each firm's latest target with its previous one: 3 raised their price target, 1 lowered it, 5 left it unchanged and 2 have their first observed target in the past year.

No firm's latest available rating differs from its previous one.

Latest observed target change: Morgan Stanley raised its target from $19.00 (set 12 Aug 2026) to $21.00 on 3 Nov 2026.

Last 1 year. Latest opinion per identifiable analyst within the last 1 year. BUY / HOLD / SELL each count one current analyst vote; unnamed firm records are a fallback.

FirmAnalystLatest ratingReport dateLatest target (USD)
BairdBrian SkorneyConflictConflicting reports · excluded22 Oct 202648.00 USD
Bank of America SecuritiesJason GerberrySell29 Jun 202611.00 USD
BTIGThomas ShraderBuy18 Nov 202516.00 USD
Canaccord GenuitySumant KulkarniConflictConflicting reports · excluded28 Aug 2026Conflicting reports · excluded
Cantor FitzgeraldPete StavropoulosBuy23 Mar 2026—
CitigroupSamantha SemenkowBuy18 Sep 202617.00 USD
Deutsche BankUnnamed analystBuy26 Jun 2026—
Goldman SachsCorinne JohnsonBuy14 May 202625.00 USD
H.C. WainwrightDouglas TsaoHold10 Sep 202610.00 USD
JPMorganTessa RomeroBuy20 Nov 202515.00 USD
Leerink PartnersMarc GoodmanBuy22 Oct 202626.00 USD
Morgan StanleyTerence FlynnBuy12 Aug 202619.00 USD
NeedhamUnnamed analyst—29 Jun 202611.00 USD
Piper SandlerAllison M BratzelBuy17 Aug 202630.00 USD
Raymond JamesChris RaymondBuy8 Oct 202630.00 USD · 10 Aug 2026
RBC Capital MarketsLeonid TimashevHold23 Oct 202622.00 USD
TD CowenTyler Van BurenBuy12 Aug 202630.00 USD
UBSAshwani VermaHold3 Nov 202611.00 USD
Weiss RatingsUnnamed analyst—28 Aug 2026—
William BlairMyles R MinterHold11 Aug 2026—
Data feed RESEARCHResearch TeamHold15 Jun 2026—

Partial coverage · checked 6 Nov (6 Nov 2026, 02:56 ET). Some research records could not be refreshed. Cached records retained. Prices stream live during the US session; otherwise stored prices delayed about 15 minutes. A summary of analyst opinion, not investment advice.